Article

Evolution of Personalized Care

From Cohort Segmentation to Precision Medicine

Artira-Exploring-Payer-to-Payer-data-exchange_1
Aritra Roy

Sr. Healthcare Consultant,
CitiusTech

calendar 1

24 - May

Personalized care has long been associated with improved clinical outcomes and patient satisfaction. However, a question remains: Was care truly personalized in the past, or is precision medicine just the beginning of a truly tailored approach to Healthcare?

The concept of personalized care has seen quite a transformative journey over the years with the growing adoption of modern technologies and a deeper, ever-maturing knowledge of human biology and disease mechanisms. We are witnessing a paradigm shift from the traditional "one-size-fits-all" approach to more tailored and individualized treatments that are rooted in an understanding that each individual is unique, and so is their disease process. 

Cohort-Based segmentation: Initial years of personalized care

An aging population, a rising prevalence of chronic conditions, and a promising value-based care ecosystem have pushed Healthcare organizations to shift from population-based care to personalized care strategies. This led to the adoption of cohort-based segmentation, the process of grouping patients based on shared characteristics, such as medical history, demographic factors, or predicted Healthcare needs. Cohort-based segmentation combined with a Healthcare Provider’s clinical expertise, guarantees the delivery of scientifically substantiated treatments and medicines to unique individual scenarios. It is widely adopted to deliver focused Healthcare interventions with efficient resource allocations without losing the focus on personalization.

Picture1-May-24-2024-03-50-59-7999-PM

Traditionally, cohorts have been defined using rule-based or standard algorithm-based methods, such as Hierarchical Condition Categories (HCCs) or Adjusted Clinical Groups (ACGs). A rule-based system might group patients by age and diagnosed chronic conditions, while standard algorithms could use statistical methods to find patterns in patient data, identifying those at risk of hospital readmission. 

While these approaches provide a valuable starting point, they often fail to capture the complex interplay of factors such as medication adherence, lifestyle behaviors, and social determinants of health that can significantly impact disease progression and treatment response.

Industry Example: Aetna

Resources For Living program used Social Isolation index to identify high risk MA members for social isolation and clinical risk. Permitted interventions to address loneliness and social isolation.

Picture2-May-24-2024-03-53-29-9856-PMThe Role of clinical guidelines for cohort-based member segmentation

Clinical guidelines are evidence-based recommendations that provide a framework to make informed decisions about appropriate treatments, diagnostics, and care pathways for specific clinical circumstances. In the context of personalized care, clinical guidelines can enable precise member segmentation. By mapping patient data against established clinical guidelines, Healthcare organizations can identify cohorts or subgroups of patients who share specific clinical characteristics, risk factors, or treatment requirements. 

With the CMS Interoperability & Prior Authorization Final Rule (CMS-0057-F), there is a lot of traction in the industry to convert clinical guidelines into Clinical Quality Language (CQL) Rules for Documentation Template Requirement (DTR) workflow. Leveraging this conversion, the adoption of CQL-based clinical guidelines can be used to enhance member segmentation efforts. CQL-based clinical guidelines can be used to automate the process of identifying patients who meet specific criteria or require specific interventions based on their individual characteristics and clinical data. 

For example, a CQL-based clinical guideline for diabetes management could be used to automatically identify patients with uncontrolled blood glucose levels, comorbidities such as hypertension or obesity, or those who are overdue for recommended screenings or follow-up visits. These patients could then be segmented into appropriate cohorts for targeted interventions, personalized care plans, or enrollment in disease management programs.

AI/ML-powered cohort optimization: Better but not the best

We understand that the success of personalization depends on the ability to accurately identify and optimize patient cohorts. This was a challenge that troubled the industry for a long time. With the rise of big data and machine learning capabilities, Healthcare organizations began employing AI/ML models to optimize cohort segmentation. Cohort optimization, segmenting populations into further granular, clinically relevant subgroups, offers a transformative solution to the healthcare industry. By integrating diverse data streams, from electronic health records (EHRs) and claims data to socioeconomic and genomic insights, a 360-degree view of each patient can be constructed revealing hidden patterns and nuances that traditional segmentation models overlook.  

Industry Example: Kaiser Permanente

Senior Segmentation model to identify older adults in care groups with similar needs, trajectories, and utilization patterns. Optimized member selection for higher need (+11%) & lower need groups (-4%).

For example, an HCC-based cohort of patients with type 2 diabetes might be grouped based on broad metrics like HbA1c levels or the presence of comorbidities. However, cohort optimization could further refine these subgroups by layering in data on medication adherence, lifestyle factors, and even genetic markers that influence treatment response. Armed with these optimized cohorts, care management teams can deploy targeted interventions tailored to each segment's unique needs. Cardiovascular disease cohorts may receive care pathways focused on cholesterol management, hypertension control, lifestyle interventions like dietary changes and exercise regimens that are applicable broadly to that patient population. While kidney disease cohort management would follow standardized protocols like medication adherence programs, dialysis schedules, dietary restrictions, etc. tailored for that overall disease group.

The key point is that, while cohort optimization represented a significant step forward, it still relied on the average characteristics and needs of the full cohort population, rather than persona-level data.

Emergence of precision medicine: Personalized insights for individualized care

The mapping of the human genome and advances in omics technologies (genomics, proteomics, metabolomics, etc.) enabled a deeper understanding of human biology and the molecular basis of disease. Today, the focus is on personalized medicine or precision medicine that tailors Healthcare to individual differences in people’s genes, environments, and lifestyles. This approach goes beyond even AI-enhanced cohort optimization by aiming for interventions that are customized to each patient’s unique physiological profile. 

Precision medicine allows for a more accurate diagnosis, more precise treatment, and better prevention strategies. It has an “N-of-1” philosophy – treating each person as a unique case rather than part of a cohort.  By understanding the unique genetic makeup of an individual, doctors can predict the likelihood of a disease occurring and take preventive measures. It can help identify which treatments will be most effective for a particular patient, reducing the trial-and-error approach often used in medicine. This not only leads to better outcomes, but also reduces the risk of side effects. For a patient with a cardiovascular disease, instead of cohort-wide standards, precision care would utilize genetic profiling to identify personal variants impacting heart disease risk, cholesterol levels, etc., integrate personal data like genetics, digital biomarkers and leverage ML models to predict optimal prevention strategies, medications and procedures customized for that patient. 

In oncology, genetic sequencing of a tumor can identify specific mutations driving cancer growth and treatments can then be tailored to target those mutations. Precision care enables a lung-cancer patient with a mutation in the ALK gene, to receive the ALK inhibitors, which are more effective than standard chemotherapy, and evidently more personalized.

Picture3-May-24-2024-03-55-10-1429-PM

Industry Example: Humana

‘Bold Goal’ used precision segmentation to understand the unique needs of its MA populations for targeted interventions. MA members saw 816K+ healthy days with targeted intervention. 

Individualized care with hyper-personalized insights: Future looking

The latest advancements are focused on developing integrated knowledge bases that consolidate multi-dimensional personal data - genomic, clinical, behavioral, environmental - to generate hyper-personalized insights for guiding prevention strategies, diagnostics, therapeutics, and disease management on a per-individual basis. AI models can now process these comprehensive personal data profiles to recommend precise interventions optimized for each person.

Conclusion

The evolving personalization of evidence-based care – from cohort-based segmentation to AI-powered cohort optimization and precision medicine – is intimately related to the increasing comprehension and adoption of state-of-the-art technology in Healthcare practices. By leveraging the power of data analytics, genomics, and emerging technologies, care delivery has now shifted from standardized to hyper-personalized, predictive, and pre-emptive care tailored to each individual's requirements throughout his/her health journey.

  1.  

Related Articles

Accelerating clinical development

Accelerating clinical development

Liquid biopsies with radiology directed biopsy

Liquid biopsies with radiology directed biopsy

Enhancing Payer prior authorization workflows

Enhancing Payer prior authorization workflows

Revenue Cycle Modernization in the 2020's

Revenue Cycle Modernization in the 2020's

Transforming web accessibility with the power of Gen AI

Transforming web accessibility with the power of Gen AI

Revolutionizing medical imaging workflow

Revolutionizing medical imaging workflow

Navigating 2025 MIPS quality measures

Navigating 2025 MIPS quality measures

Navigating the complexities of healthcare cybersecurity

Navigating the complexities of healthcare cybersecurity

Streamlining healthcare cloud expenses

Streamlining healthcare cloud expenses

Engineering breakthroughs

Engineering breakthroughs

Future-forward marketing

Future-forward marketing

Building a sustainable compliance framework

Building a sustainable compliance framework

Four top reasons for Cloud spend wastage

Four top reasons for Cloud spend wastage

The five key digital shifts

The five key digital shifts

Driving patient centric success

Driving patient centric success

Adopting Interoperability

Adopting Interoperability

Advancing to transformative revenue cycle

Advancing to transformative revenue cycle

Alcohol SBI (Screening and Brief Intervention)

Alcohol SBI (Screening and Brief Intervention)

Azure data migration strategies

Azure data migration strategies

Building a unified vision

Building a unified vision

Navigating Consent Management in patient-centric care

Navigating Consent Management in patient-centric care

Diagnosis to treatment

Diagnosis to treatment

Digital healthcare experience

Digital healthcare experience

Digital innovations in pharmaceuticals

Digital innovations in pharmaceuticals

Digital transformation

Digital transformation

Innovations in drug discovery in a post-pandemic world

Innovations in drug discovery in a post-pandemic world

Embracing digital transformation in patient hub services

Embracing digital transformation in patient hub services

Enabling remote monitoring for personalized healthcare

Enabling remote monitoring for personalized healthcare

Shift Left Testing

Shift Left Testing

Pioneering healthcare in the digital landscape

Pioneering healthcare in the digital landscape

Explore the transformative power of GenAI

Explore the transformative power of GenAI

Exploring Payer-to-Payer data exchange

Exploring Payer-to-Payer data exchange

From enrollment to improving member health

From enrollment to improving member health

Generative AI in healthcare

Generative AI in healthcare

Humanizing healthcare

Humanizing healthcare

Next-Gen data integration & Interoperability

Next-Gen data integration & Interoperability

Imaging informatics

Imaging informatics

Laying the foundation

Laying the foundation

Optimizing medical device maintenance

Optimizing medical device maintenance

Mastering FinOps on AWS

Mastering FinOps on AWS

Navigating global regulations for SaMD

Navigating global regulations for SaMD

Effective contract management in value-based care

Effective contract management in value-based care

Unlocking Cloud potential for Payers

Unlocking Cloud potential for Payers

Safeguarding the future of radiology

Safeguarding the future of radiology

Scaling healthcare innovation

Scaling healthcare innovation

The future of healthcare

The future of healthcare

The interoperability upgrade

The interoperability upgrade

The rise of value-based care

The rise of value-based care

Think beyond monitoring

Think beyond monitoring

Understanding FinOps

Understanding FinOps

Unleashing the potential of Cloud partnerships

Unleashing the potential of Cloud partnerships

Revolutionizing efficiency in healthcare

Revolutionizing efficiency in healthcare

Transforming specialty care through value-based digital strategies

Transforming specialty care through value-based digital strategies

Healthcare trends 2023

Healthcare trends 2023

Trust is all you need

Trust is all you need

Navigating Healthcare Transformation

Navigating Healthcare Transformation

Prioritizing Patient Care: Medical Technology Innovations on the Horizon

Prioritizing Patient Care: Medical Technology Innovations on the Horizon

Navigating the complexities of risk adjustment

Navigating the complexities of risk adjustment

Overcoming prior authorization challenges in healthcare Payer plans

Overcoming prior authorization challenges in healthcare Payer plans

Decoding Gen AI as an enabler

Decoding Gen AI as an enabler

Small Device, Big Impact: Apple’s Role in the Hearing Aid Market

Small Device, Big Impact: Apple’s Role in the Hearing Aid Market

Mastering Cloud Cost Management

Mastering Cloud Cost Management

ICHRA vs. Traditional group health plans

ICHRA vs. Traditional group health plans

Personalized care with Gen AI-powered risk stratification

Personalized care with Gen AI-powered risk stratification

Empowering healthcare

Empowering healthcare

Modernizing healthcare

Modernizing healthcare

Navigating trends and focus areas

Navigating trends and focus areas

Can specialized models tame

Can specialized models tame

Evolution of Personalized Care

Evolution of Personalized Care

Cloud-based imaging

Cloud-based imaging

Putting price transparency rules to advantage

Putting price transparency rules to advantage